Combined features based on MT1-MMP expression, CD11b + immunocytes density and LNR predict clinical outcomes of gastric cancer

Table 4 Multivariate analyses of factors associated with OS

Factors	OS
	HR	95% CI	P
Model 1
Tumor size: <16 cm²vs ≥16 cm²	1.821	1.168-2.839	0.008
Serosa invasion (T stage): T1-2 vs T3-4	3.232	1.440-7.251	0.004
Lymoh nodes metastasis: No vs Yes	1.012	0.610-1.679	0.964
Surgery types: SR vs TR/CR	2.030	1.128-3.653	0.018
LNR: low (≤0.33) vs High (>0.33)	1.957	1.233-3.108	0.004
MT1-MMP: Negative vs Positive	2.596	1.496-4.506	0.001
CD11b + immunocytes density: High vs Low	1.838	1.183-2.855	0.007
Model 2
Tumor size: <16 cm²vs ≥16 cm²	1.734	1.120 - 2.686	0.014
Serosa invasion (T stage): T1-2 vs T3-4	3.013	1.360 - 6.674	0.007
Lymoh nodes metastasis: No vs Yes	0.696	0.404 - 1.200	0.192
Surgery types: SR vs TR/CR	2.023	1.134 - 3.606	0.017
Combined features: Group I vs Group II	3.818	2.223 - 6.557	<0.001

OS: overall survival; HR: hazard ratio; NA: not adopted; SR: subtotal resection; TR: total resection; CR: combined resection; LNR: lymph node ratio.

ISSN: 1479-5876